Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

They began 2024 saying "I do" to each other at a ritzy wedding ceremony. Back then, a glamorous Scottsdale couple hardly ...

Medical Properties Trust investors took a hit from Prospect Medical's bankruptcy filings, but stock has largely consolidated.

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

For 2025, Abbott forecast organic sales growth of between 7.5% and 8.5%, as well as adjusted earnings per share of $5.05 to $5.25. Analysts expect $5.16 a share on $42 billion in sales.

Key Takeaways Johnson & Johnson's fourth quarter sales met estimates, while net income fell short.After adjusting for ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

SHIZUOKA, Japan -- Japanese machine tool manufacturer Star Micronics aims to increase its sales volume in India tenfold with an eye on the country's rapidly growing appetite for medical devices.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

PROVIDENCE, R.I. (WPRI) — Providence Mayor Brett Smiley joined 12 News at 4 to talk about what’s ahead for the capital city ...